hexamethylene bisacetamide has been researched along with Teratocarcinoma in 2 studies
N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208
Teratocarcinoma: A malignant neoplasm consisting of elements of teratoma with those of embryonal carcinoma or choriocarcinoma, or both. It occurs most often in the testis. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The multipotent human teratocarcinoma (TC) cell NTera-2 clone D1 (abbreviated NT2/D1) differentiates into a neuronal lineage after retinoic acid (RA) treatment and a distinct phenotype after hexamethylene bisacetamide (HMBA) treatment." | 7.69 | All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-alpha and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas. ( Baselga, J; Dmitrovsky, E; Grippo, JF; Kurie, J; Lucas, DA; Maerz, WJ; Masui, H; Miller, WH; Moy, D, 1994) |
| "The multipotent human teratocarcinoma (TC) cell NTera-2 clone D1 (abbreviated NT2/D1) differentiates into a neuronal lineage after retinoic acid (RA) treatment and a distinct phenotype after hexamethylene bisacetamide (HMBA) treatment." | 3.69 | All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-alpha and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas. ( Baselga, J; Dmitrovsky, E; Grippo, JF; Kurie, J; Lucas, DA; Maerz, WJ; Masui, H; Miller, WH; Moy, D, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, WH | 1 |
| Maerz, WJ | 1 |
| Kurie, J | 1 |
| Moy, D | 1 |
| Baselga, J | 1 |
| Lucas, DA | 1 |
| Grippo, JF | 1 |
| Masui, H | 1 |
| Dmitrovsky, E | 1 |
| Wakeman, JA | 1 |
| Walsh, J | 1 |
| Andrews, PW | 1 |
2 other studies available for hexamethylene bisacetamide and Teratocarcinoma
| Article | Year |
|---|---|
All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-alpha and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas.
Topics: Acetamides; Antineoplastic Agents; Cell Differentiation; Cell Division; Cell Line; Clone Cells; Drug | 1994 |
Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
Topics: Acetamides; Base Sequence; Carcinoma, Embryonal; Cell Differentiation; Drosophila Proteins; Frizzled | 1998 |